NicOx Announces Initiation Of First Phase 1 Study Of Investigational Nitric Oxide-Donating Agent...

NicOx S.A. (Eurolist: COX) announced that Merck & Co., Inc. has initiated the first in a series of planned clinical studies, in mild to moderate hypertensive patients, under the companies' collaborative agreement to develop new nitric oxide-donating antihypertensive agents using NicOx'... [read full story]                    

Add Comment
There are also 9 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies